|1.||Hypoprothrombinemias (Prothrombin Deficiency)
01/01/1954 - "[The test of tromexan hypoprothrombinemia in the study of hepatic function]."
01/08/1953 - "The effect of intravenous injection of emulsified vitamin K1 on the hypoprothrombinemia induced by tromexan."
03/01/1998 - "The aim of this work has been to assess the feasibility of using Prothrombin Time (PT) Assay before and after administration of Pelentan (Hypoprothrombinemia Provocation (HPP) Test) for early detection of subclinical toxic hepatic injuries. "
01/01/1953 - "Vitamin K as antagonist to anticoagulants; the effect of synthetic vitamin K (menadione) and vitamin K1 in hypoprothrombinemia induced by dicoumarol, tromexan and phenylindanedione."
11/01/1955 - "[Pelentan therapy in puerperal thrombosis]."
02/23/1952 - "[Prevention of thrombosis with tromexan in puerperium]."
01/01/1951 - "[Tromexan prophylaxis and therapy of thrombosis]."
01/10/1953 - "[Treatment of thromboses and embolisms in obstetrics and gynecology with the liquemin-depot Roche and with tromexan]."
09/28/1950 - "[Prophylaxis of thrombosis with tromexan in closed fractures of the leg]."
03/01/1968 - "[Our experiences with long-term treatment with Pelentan in myocardial infarct]."
11/01/1965 - "[Blood coagulation tests following prolonged pelentan treatment of patients recovering from myocardial infarction]."
11/28/1952 - "[Hazards and indications for pelentan therapy of myocardial infarction]."
01/01/1950 - "The treatment of coronary thrombosis and fresh myocardial infarction with a new anticoagulant tromexan."
01/01/1952 - "[The treatment of myocardial infarction by dicumarol and its derivatives (tromexan); its biological control]."
07/01/1953 - "[Pelentan therapy of thrombophlebitis]."
01/01/1953 - "[The use of tromexan in thrombophlebitis; two years of experience in the Clinique de la Source, in Lausanne]."
08/28/1952 - "[Tromexan therapy of thrombophlebitis]."
11/15/1952 - "[Experience with the treatment of thrombophlebitis with simultaneous application of pelentan and vitamin E]."
03/01/1951 - "[Use of anticoagulants in dermatology; use of tromexan (ethyl ester of di-4-hydroxy-coumarinyl acetic acid) in ulcus cruris in dystrophy with thrombophlebitis and in related conditions]."
|5.||Embolism and Thrombosis
11/21/1952 - "[Pelentan therapy of arterial thrombosis and embolism]."
03/01/1952 - "[Tromexan in the treatment of thrombosis and embolism in urology]."
01/01/1954 - "[Treatment of thrombosis and embolism with the anticoagulants thrombocid and tromexan with special experimental reference to depot thrombocid]."
01/01/1951 - "[Experiences with thrombocid, dicumarol and tromexan in the prophylaxis and treatment of thrombosis and embolism]."
|6.||Prothrombin (Factor II)
|7.||Vitamin K 1 (Phylloquinone)
|8.||Aspirin (Acetylsalicylic Acid)
|10.||Vitamin K 3 (Menadione)